The average price target for Edgewise Therapeutics, Inc. is 35.25. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $51.00 ,the lowest forecast is $16.00. The average price target represents 20.27% Increase from the current price of $29.31.